Physician profile
Neil E Roundy
NPI 1174723720
$9,924.65
in general payments reported to CMS, 2019-2025
17 companies · $271 in 2025
The $271 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $4,829 · 2021: $2,438 · 2022: $1,278 · 2023: $665 · 2024: $165 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $5,974.50 | 2020-2022 | |
| Centinel Spine, LLC | $927.20 | 2022 | |
| Surgalign Spine Technologies, INC. | $920.71 | 2021-2022 | |
| Alphatec Spine, INC | $592.48 | 2023 | Invictus Mis |
| Stryker Corporation | $530.45 | 2019-2022 | |
| Boston Scientific Corporation | $427.78 | 2019-2025 | General - Dbs |
| Medtronic USA, INC. | $247.52 | 2019-2020 | |
| Orthofix Medical, INC. | $105.38 | 2024 | Mariner |
| Kuros Biosciences USA, INC | $54.88 | 2025 | Magnetos |
| Cerapedics INC. | $30.54 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Abbott Laboratories | $30.32 | 2025 | Eterna |
| Nanohive Medical LLC | $22.24 | 2025 | Hive C, Csa, Alif, Tlif |
| Alafair Biosciences, INC. | $21.80 | 2025 | Versawrap |
| Medtronic, INC. | $20.70 | 2025 | Stealthstation S8 Platform |
| Spineology INC. | $18.15 | 2025 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$9,261,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Roundy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.